Journal of Yeungnam Medical Science

Yeungnam University College of Medicine, Yeungnam University Institute Medical Science (영남대 의대 학술지 편집위원회)
권호 표지
DOI QR코드

DOI QR Code

Catastrophic catecholamine-induced cardiomyopathy rescued by extracorporeal membrane oxygenation in recurrent malignant pheochromocytoma

  • Received : 2019.03.27
  • Accepted : 2019.05.08
  • Published : 2019.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Pheochromocytoma (PCC) is a rare catecholamine-producing tumor with the incidence in hypertension of 0.1-0.6%. PCC crisis is an endocrine emergency that can lead to hemodynamic disturbance and organ failure such as catecholamine-induced cardiomyopathy. The circulatory collapse caused by it often requires mechanical support. The author reports an unusual case in which a patient who previously underwent surgery for malignant PCC developed catecholamine-induced cardiomyopathy, and successfully recovered using extracorporeal membrane oxygenation.

Keywords

References

  1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005;366:665-75. https://doi.org/10.1016/S0140-6736(05)67139-5
  2. Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014;99:1915-42. https://doi.org/10.1210/jc.2014-1498
  3. Whitelaw BC, Prague JK, Mustafa OG, Schulte KM, Hopkins PA, Gilbert JA, et al. Phaeochromocytoma crisis. Clin Endocrinol (Oxf) 2014;80:13-22. https://doi.org/10.1111/cen.12324
  4. Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. Cardiovascular manifestations of phaeochromocytoma. J Hypertens 2011;29:2049-60. https://doi.org/10.1097/HJH.0b013e32834a4ce9
  5. Suh IW, Lee CW, Kim YH, Hong MK, Lee JW, Kim JJ, et al. Catastrophic catecholamine-induced cardiomyopathy mimicking acute myocardial infarction, rescued by extracorporeal membrane oxygenation (ECMO) in pheochromocytoma. J Korean Med Sci 2008;23:350-4. https://doi.org/10.3346/jkms.2008.23.2.350
  6. Sojod G, Diana M, Wall J, D'Agostino J, Mutter D, Marescaux J. Successful extracorporeal membrane oxygenation treatment for pheochromocytoma-induced acute cardiac failure. Am J Emerg Med 2012;30:1017.e1-3. https://doi.org/10.1016/j.ajem.2011.05.006
  7. Giavarini A, Chedid A, Bobrie G, Plouin PF, Hagege A, Amar L. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma. Heart 2013;99:1438-44. https://doi.org/10.1136/heartjnl-2013-304073
  8. Otusanya O, Goraya H, Iyer P, Landi K, Tibb A, Msaouel P. A vicious cycle of acute catecholamine cardiomyopathy and circulatory collapse secondary to pheochromocytoma. Oxf Med Case Reports 2015;2015:343-5. https://doi.org/10.1093/omcr/omv058
  9. Yi DW, Kim SY, Shin DH, Kang YH, Son SM. Pheochromocytoma crisis after a dexamethasone suppression test for adrenal incidentaloma. Endocrine 2010;37:213-9. https://doi.org/10.1007/s12020-009-9303-y
  10. An JY, Kim DR, Oh JY, Han YC, Lee IS, Kown TJ, et al. A case of recurrent glucocorticoid-induced pheochromocytoma crisis during the treatment of urticarial. Korean J Med 2015;88:564-9. https://doi.org/10.3904/kjm.2015.88.5.564
  11. Barrett C, van Uum SH, Lenders JW. Risk of catecholaminergic crisis following glucocorticoid administration in patients with an adrenal mass: a literature review. Clin Endocrinol (Oxf) 2015;83:622-8. https://doi.org/10.1111/cen.12813
  12. Tischler AS, Perlman RL, Morse GM, Sheard BE. Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures. J Neurochem 1983;40:364-70. https://doi.org/10.1111/j.1471-4159.1983.tb11291.x
  13. McMahon A, Sabban EL. Regulation of expression of dopamine beta-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues. J Neurochem 1992;59:2040-7. https://doi.org/10.1111/j.1471-4159.1992.tb10092.x
  14. Yang S, Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2004;2:1-12. https://doi.org/10.2174/1570161043476483
  15. Harari A, Inabnet WB 3rd. Malignant pheochromocytoma: a review. Am J Surg 2011;201:700-8. https://doi.org/10.1016/j.amjsurg.2010.04.012
  16. Baudin E, Habra MA, Deschamps F, Cote G, Dumont F, Cabanillas M, et al. Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma. Eur J Endocrinol 2014;171:R111-22. https://doi.org/10.1530/EJE-14-0113
  17. Tanaka S, Ito T, Tomoda J, Higashi T, Yamada G, Tsuji T. Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion. Intern Med 1993;32:789-94. https://doi.org/10.2169/internalmedicine.32.789
  18. Ilias I, Divgi C, Pacak K. Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer. Semin Nucl Med 2011;41:364-8. https://doi.org/10.1053/j.semnuclmed.2011.03.003